Oasis Management Company’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.47M	Sell	583,490 -143,671	-20%	-$2.54M	1.12%	23
2025 Q4	$13.6M	Sell	727,161 -391,774	-35%	-$6.5M	1.76%	13
2025 Q3	$16.3M	Hold	1,118,935	–	–	2.77%	12
2025 Q2	$12.3M	Hold	1,118,935	–	–	2.9%	13
2025 Q1	$9.99M	Buy	1,118,935 +3,170	+0.3%	+$29.5K	3.27%	15
2024 Q4	$10.5M	Hold	1,115,765	–	–	3.39%	11
2024 Q3	$8.99M	Sell	1,115,765 -42,200	-4%	-$366K	3.07%	14
2024 Q2	$9.82M	Hold	1,157,965	–	–	3.13%	10
2024 Q1	$10.4M	Buy	1,157,965 +151,107	+15%	+$1.4M	3.52%	8
2023 Q4	$11.3M	Buy	1,006,858 +53,604	+6%	+$539K	3.82%	11
2023 Q3	$8.23M	Buy	953,254 +306,981	+48%	+$2.96M	2.2%	16
2023 Q2	$6.69M	Buy	646,273 +23,997	+4%	+$265K	2.33%	18
2023 Q1	$6.75M	Buy	622,276 +325,316	+110%	+$3.44M	1.27%	23
2022 Q4	$3.33M	Hold	296,960	–	–	0.71%	25
2022 Q3	$3.01M	Buy	+296,960	New	+$2.78M	0.52%	30